Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;2012(Suppl 4):10.4172/2157-7609.S4-001.
doi: 10.4172/2157-7609.S4-001. Epub 2012 Mar 19.

Characterization of UDP-glucuronosyltransferase (UGT1A1) Promoter Polymorphisms and Gene Expression on Ethnicity, Stage of Disease, and Menopausal Status in Breast Cancer

Affiliations

Characterization of UDP-glucuronosyltransferase (UGT1A1) Promoter Polymorphisms and Gene Expression on Ethnicity, Stage of Disease, and Menopausal Status in Breast Cancer

Athena Starlard-Davenport et al. J Drug Metab Toxicol. 2012.

Abstract

Estrogen metabolism, catalyzed by UGTs, is a major drug-metabolic pathway that results in inactivation of estrogens and their metabolites. Alterations in UGTs involved in estrogen metabolism, has been suggested to play a role in breast cancer risk. The purpose of this study was to: 1) compare the mRNA expression levels of UGTs involved in estrogen metabolism in human breast tissues from women; 2) compare UGT1A1 mRNA expression to tumor stage, ethnicity, and menopausal status in a group of human breast tumors and normal breast tissues, and 3) investigate the association between variations in the number of TA repeats in the promoter region of UGT1A1 to gene expression. Quantification of UGT mRNA in breast tissues revealed that UGT1A4, UGT1A10, and UGT2B7 mRNA levels were decreased in breast cancers as compared to normal breast tissues. UGT1A1 mRNA levels were also significantly decreased in breast cancers as compared to normal breast tissues (Tumor: 0.5 ± 0.2; Normal: 4.1 ± 1.3, p = 0.0006). UGT1A1 mRNA down-regulation was strongly correlated with postmenopausal status in breast cancer versus controls (p = 0.04). In all the UGT1A1 genotypes observed in our study, the mean mRNA levels was significantly decreased among breast cancer cases as compared to controls for UGT1A1*1/*1 (p = 0.004), UGT1A1*28/*28 (p = 0.03) and UGT1A1*28/*37 (p = 0.06). Our findings demonstrate that further investigations are necessary to determine the role of UGT1A1 in breast carcinogenesis.

Keywords: Breast cancer; Genetic polymorphism; UGT1A1; UGTs.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. mRNA expression of UGTs in human breast samples relative to B-actin.
Quantitative real-time PCR analysis of UGT1A1, UGT1A4, UGT1A10, and UGT2B7 mRNA expression in normal and tumor breast tissues. Solid horizontal lines demonstrate the mean with the 95% CI of each individual group. All data are shown as the ratio between the UGT target gene and B-actin internal control on a logarithmic scale. p -value, nonparametric, Mann-Whitney tests. *p<0.05, **p <0.01 is statistically significant.
Figure 2:
Figure 2:. Effect of UGT1A1 mRNA expression in human breast samples on ethnicity, menopausal status, and stage of breast disease.
Quantitative real-time PCR analysis of UGT1A1 mRNA expression in normal (N) and tumor (T) human breast tissues and its effect on ethnicity (A), menopausal status (B), and stage of breast disease (C). Solid horizontal lines demonstrate the mean with the 95% CI of each individual group. All data are shown as the ratio between the UGT target gene and B-actin internal control on a logarithmic scale. p -value, nonparametric, Mann-Whitney or Kruskall-Wallis tests. *p < 0.05 is statistically significant.

Similar articles

Cited by

References

    1. Cancer facts and figures (2010) American Cancer Society.
    1. Abdel-Haleem AM, El-Zeiry MI, Mahran LG, Abou-Aisha K, Rady MH, et al. (2011) Expression of RFC/SLC19A1 is Associated with Tumor Type in Bladder Cancer Patients. PLoS One 6: e21820. - PMC - PubMed
    1. Memon AA, Sorensen BS, Melgard P, Fokdal L, Thykjaer T, et al. (2004) Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients. Br J Cancer 91: 2034–2041. - PMC - PubMed
    1. Reznikoff CA, Sarkar S, Jülicher KP, Burger MS, Puthenveettil JA, et al. (2000) Genetic alterations and biological pathways in human bladder cancer pathogenesis. Urol Oncol 5: 191–203. - PubMed
    1. Feigelson H, Henderson B (1996) Estrogens and breast cancer. Carcinogenesis 17: 2279–2284. - PubMed

LinkOut - more resources